Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Other Accumulated Expenses (2010 - 2024)

Veru (VERU) posted quarterly Other Accumulated Expenses of $2.4 million for Q1 2024, down 13.73% year-over-year from $2.8 million in Q2 2023, and up 16.38% quarter-over-quarter from $2.1 million in Q4 2023.

Veru (VERU) Other Accumulated Expenses (2010 - 2024) Analysis & Trends

Veru (VERU) has reported Other Accumulated Expenses for 15 consecutive years, with $2.4 million the latest figure, recorded in Q1 2024.

  • In Q1 2024, Other Accumulated Expenses fell 13.73% year-over-year to $2.4 million; the TTM figure through Mar 2024 stood at $2.4 million (down 13.73% YoY), while the FY2023 annual figure was $2.0 million, down 11.66% from the prior year.
  • Other Accumulated Expenses rose to $2.4 million in Q1 2024 per VERU's latest filing, from $2.1 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $7.0 million in Q4 2022 and bottomed at $1.2 million in Q3 2020.
  • Historically, Other Accumulated Expenses has averaged $2.3 million across 5 years, with a median of $2.1 million in 2021.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses jumped 342.22% — and 2023, when it plunged 70.35%.
  • Veru's Other Accumulated Expenses stood at $2.1 million in 2020, then decreased by 24.38% to $1.6 million in 2021, then surged by 342.22% to $7.0 million in 2022, then sank by 70.35% to $2.1 million in 2023, then advanced by 16.38% to $2.4 million in 2024.
  • Business Quant data shows VERU's Other Accumulated Expenses at $2.4 million in Q1 2024, $2.1 million in Q4 2023, and $2.0 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Veru 60.85 Mn 35.06 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 2.43 Mn
Dec 31, 2023 2.08 Mn
Sep 30, 2023 1.99 Mn
Jun 30, 2023 2.79 Mn
Mar 31, 2023 2.81 Mn
Dec 31, 2022 7.03 Mn
Sep 30, 2022 2.25 Mn
Jun 30, 2022 2.13 Mn
Mar 31, 2022 2.19 Mn
Dec 31, 2021 1.59 Mn
Sep 30, 2021 1.62 Mn
Jun 30, 2021 2.10 Mn
Mar 31, 2021 1.97 Mn
Dec 31, 2020 2.10 Mn
Sep 30, 2020 1.18 Mn
Jun 30, 2020 1.75 Mn
Mar 31, 2020 1.78 Mn
Dec 31, 2019 2.13 Mn
Sep 30, 2019 1.44 Mn
Jun 30, 2019 2.40 Mn